Development of Personalized Strategies for Precisely Battling Malignant Melanoma

Armond J Isaak1, GeGe R Clements1, Rand Gabriel M Buenaventura1

  • 1Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Insights

Melanoma, a deadly skin cancer, presents treatment challenges due to resistance and toxicity. This review explores standard therapies and emerging personalized oncology strategies to overcome these barriers.

Area of Science:

  • Oncology
  • Dermatology
  • Genetics

Background:

  • Melanoma is a severe skin cancer with significant molecular heterogeneity.
  • Standard treatments like immune checkpoint inhibitors and targeted therapies are used for advanced melanoma.
  • Resistance and toxicity limit the effectiveness of current melanoma treatments.

Purpose of the Study:

  • To review the current landscape of standard melanoma therapies.
  • To explore personalized oncology techniques for melanoma treatment.
  • To summarize tools for overcoming barriers in melanoma management.

Main Methods:

  • Literature review of standard melanoma therapies.
  • Exploration of personalized oncology approaches.
  • Synthesis of current research on melanoma treatment strategies.

Main Results:

  • Standard therapies (immune checkpoint inhibitors, targeted therapies) have limitations.
  • Acquired resistance and toxicity are significant challenges.
  • Personalized oncology offers potential novel strategies.

Conclusions:

  • Novel strategies are needed to address resistance and toxicity in melanoma.
  • Personalized oncology holds promise for tailored melanoma treatment.
  • An updated understanding of available tools is crucial for effective melanoma management.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K